Literature DB >> 16252124

Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma?

Samet Ozlugedik1, Irfan Yorulmaz, Kursat Gokcan.   

Abstract

Laryngopharyngeal reflux (LPR) as a causative irritating factor in the development of laryngeal carcinoma has been suggested. However, the association between LPR and laryngeal carcinoma remains unclear. The aim of this study was to compare the prevalence and severity of reflux between patients with laryngeal carcinoma and clinical LPR. The intention was to find out if a correlation exists between the laryngeal findings and the level of acid reflux. The study population consisted of 29 patients with laryngeal cancer (group I), 33 LPR patients with normal laryngeal findings (group II) and 70 LPR patients with related laryngeal pathology (group III). The results of 24-h, double-channel ambulatory esophageal pH monitoring were analyzed comparing the three groups. The occurrence and severity of abnormal acid reflux at the upper and lower esophageal segments were evaluated. The incidence of LPR or gastroesophageal reflux (GER) did not vary in any of the three groups (LPR was present in 62, 42 and 56% of the patients, while GER was present in 45, 24 and 37% of the patients, respectively). Patients with LPR or GER from the three groups did not differ significantly in terms of the number of acid reflux episodes and percentage of times when the pH was <4. Our data do not support the hypothesis that LPR can be an independent risk factor in the development of larynx cancers. However, the data also do not thoroughly exclude the possibility. The reason why LPR leads to variable pathologies in the larynx may be uncovered by studies probing the differences between patients via detailed examinations of the local anti-reflux barriers such as epithelial morphology and functions.

Entities:  

Mesh:

Year:  2005        PMID: 16252124     DOI: 10.1007/s00405-005-1003-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders.

Authors:  S O Ulualp; R J Toohill; R Shaker
Journal:  Otolaryngol Head Neck Surg       Date:  1999-12       Impact factor: 3.497

2.  High incidence of laryngopharyngeal reflux in patients with head and neck cancer.

Authors:  M P Copper; C F Smit; L D Stanojcic; P P Devriese; P F Schouwenburg; L M Mathus-Vliegen
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

3.  Reflux as an etiological factor of carcinoma of the laryngopharynx.

Authors:  P H Ward; D G Hanson
Journal:  Laryngoscope       Date:  1988-11       Impact factor: 3.325

4.  Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer.

Authors:  H B El-Serag; E J Hepworth; P Lee; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

5.  [Chronic laryngitis and carcinoma (author's transl)].

Authors:  H Glanz; O Kleinsasser
Journal:  Arch Otorhinolaryngol       Date:  1976-02-08

6.  Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitis: comparison between two positions.

Authors:  P Singh; R H Taylor; D G Colin-Jones
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

Review 7.  Atypical presentation of gastroesophageal reflux disease: chest pain, pulmonary, and ear, nose, throat manifestations.

Authors:  G L Champion; J E Richter
Journal:  Gastroenterologist       Date:  1993-03

8.  Effects of gastroesophageal reflux disease in laryngeal carcinoma.

Authors:  A Bacciu; G Mercante; A Ingegnoli; T Ferri; P Muzzetto; G Leandro; F Di Mario; S Bacciu
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-10

Review 9.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

10.  Gastroesophageal reflux disease: symptoms versus pH monitoring results.

Authors:  Irfan Yorulmaz; Samet Ozlugedik; Babur Kucuk
Journal:  Otolaryngol Head Neck Surg       Date:  2003-11       Impact factor: 5.591

View more
  8 in total

Review 1.  Laryngopharyngeal reflux: the value of otolaryngology examination.

Authors:  Peter C Belafsky; Catherine J Rees
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Laryngopharyngeal Reflux : Larynx on Fire.

Authors:  R Datta; K Datta; M D Venkatesh
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study.

Authors:  Walter J Koskinen; Kjell Brøndbo; Hanna Mellin Dahlstrand; Tapio Luostarinen; Timo Hakulinen; Ilmo Leivo; Anco Molijn; Wim G Quint; Tov Røysland; Eva Munck-Wikland; Antti A Mäkitie; Ilmari Pyykkö; Joakim Dillner; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-08       Impact factor: 4.553

4.  Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma.

Authors:  Scott M Langevin; Dominique S Michaud; Carmen J Marsit; Heather H Nelson; Ariel E Birnbaum; Melissa Eliot; Brock C Christensen; Michael D McClean; Karl T Kelsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-23       Impact factor: 4.254

5.  E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux.

Authors:  Oliver Reichel; Doris Mayr; Florian Durst; Alexander Berghaus
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-05       Impact factor: 3.236

6.  The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: a preliminary report.

Authors:  Kyung Tae; Bong Joon Jin; Yong Bae Ji; Jin Hyeok Jeong; Seok Hyun Cho; Seung Hwan Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-05-31       Impact factor: 3.372

7.  Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma.

Authors:  Jia-Jie Tan; Lu Wang; Ting-Ting Mo; Jie Wang; Mei-Gui Wang; Xiang-Ping Li
Journal:  Cancer Cell Int       Date:  2019-03-20       Impact factor: 5.722

Review 8.  Pepsin and Laryngeal and Hypopharyngeal Carcinomas.

Authors:  Cheng-Yi Yin; Sha-Sha Zhang; Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-07-24       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.